Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold J G M van Megen

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2004
Glutamate and anxietyVeerle Bergink, Harold J G M van Megen, Herman G M Westenberg
Journal of Psychopharmacology (Oxford, England)|April 12, 2003
Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical careDamiaan Denys, Harold J G M van Megen, Herman G M Westenberg
The Journal of Clinical Psychiatry|April 9, 2005
Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label studySara I J Schutters, Harold J G M van Megen, Herman G M Westenberg
Psychopathology|July 9, 2004
Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measureDamiaan Denys, Femke de Geus, Harold J G M van Megen, et al.
The Journal of Clinical Psychiatry|August 25, 2004
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitorsDamiaan Denys, Femke de Geus, Harold J G M van Megen, et al.
Psychiatry Research|November 16, 2004
Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorderDamiaan Denys, Femke de Geus, Harold J G M van Megen, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorderDamiaan Denys, Nic van der Wee, Harold J G M van Megen, et al.
The Journal of Clinical Psychiatry|January 28, 2004
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorderDamiaan Denys, Harold J G M van Megen, Nic van der Wee, et al.
Journal of Affective Disorders|June 23, 2004
Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorderDamiaan Denys, Nienke Tenney, Harold J G M van Megen, et al.
The Journal of Clinical Psychiatry|September 29, 2005
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatmentNienke H Tenneij, Harold J G M van Megen, Damiaan A J P Denys, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2004
Glutamate and anxietyVeerle Bergink, Harold J G M van Megen, Herman G M Westenberg
Journal of Psychopharmacology (Oxford, England)|April 12, 2003
Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical careDamiaan Denys, Harold J G M van Megen, Herman G M Westenberg
The Journal of Clinical Psychiatry|April 9, 2005
Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label studySara I J Schutters, Harold J G M van Megen, Herman G M Westenberg
Psychopathology|July 9, 2004
Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measureDamiaan Denys, Femke de Geus, Harold J G M van Megen, et al.
The Journal of Clinical Psychiatry|August 25, 2004
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitorsDamiaan Denys, Femke de Geus, Harold J G M van Megen, et al.
Psychiatry Research|November 16, 2004
Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorderDamiaan Denys, Femke de Geus, Harold J G M van Megen, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorderDamiaan Denys, Nic van der Wee, Harold J G M van Megen, et al.
The Journal of Clinical Psychiatry|January 28, 2004
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorderDamiaan Denys, Harold J G M van Megen, Nic van der Wee, et al.
Journal of Affective Disorders|June 23, 2004
Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorderDamiaan Denys, Nienke Tenney, Harold J G M van Megen, et al.
The Journal of Clinical Psychiatry|September 29, 2005
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatmentNienke H Tenneij, Harold J G M van Megen, Damiaan A J P Denys, et al.
Pageof 4